Perspective · 10 Sep 2026
Conference abstractPublished 28 Sep 2015
Seroprevalence of Helicobactor pylori and hepatitis C virus antibodies in leukemia and malignant lymphoma
Faculty of Medicine, University of Alexandria, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The highest prevalence of Hepatitis C virus (HCV) and Helicobacter pylori has been reported in Egypt but few researches among leukemic and malignant lymphoma cases. So the present study was designed to screen acute leukemia and malignant lymphoma patients for Helicobactor pylori antibodies to six virulent antigens by a new line immunoassay and correlate the clinical status to epidemiological markers of bacterial virulence factors as well as screening the same cases to HCV antibodies as a risk cofactor and correlate between both. Cases of the present study were selected from haematology unit of Alexandria Main University Hospital from June 2012 till September 2013. One hundred leukemia/ malignant lymphoma cases who were fully investigated by clinical and laboratory tests were the candidate of our screening serological study. Acute leukemia cases were early diagnosed by CBC and bone marrow examination. Malignant lymphoma was also early diagnosed by lymph node biopsy. Screening for H. pylori antibodies to six virulent antigens were performed by line immunoassay following the manufacturer’s instructions. It was LINE test kit for the quantitative detection of H. pylori specific IgG respectively IgA antibodies in human serum. Screening for HCV antibodies were done by rapid commercial test following the manufacturer’s instructions. Our results revealed that antibodies to cytotoxin associated gene (Cag A) were predominant among cases and a significant association (p<0.05) between antibodies to vacuolating (vac) antigens of Helicobacter pylori and HCV antibodies among our leukemic and malignant lymphoma cases. We can conclude that rapid non-invasive methods by line immunoassays could easily screen hematogenous malignancies to these carcinogenic pathogens (HCV and H. pylori).
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Morsi M G”
- BylineArticles whose byline prints “Hamed N A”
- BylineArticles whose byline prints “Harfoush R A”
- BylineArticles whose byline prints “Okasha H S”
- BylineArticles whose byline prints “Goneim P A”
